Suchen
Clearmind Medicine Inc
CMNDZur Watchlist hinzufügen
2.360USD
+0.060+2.61%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
240.51KMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Clearmind Medicine Inc Unternehmen
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Clearmind Medicine Inc Informationen
BörsenkürzelCMND
Name des UnternehmensClearmind Medicine Inc
IPO-datumAug 10, 2021
CEOZuloff-Shani (Adi)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeAug 10
Addresse101-1220 West 6Th Avenue
StadtVANCOUVER
BörseNASDAQ OMX - NASDAQ BASIC
LandCanada
PostleitzahlV6H 1A5
Telefon16042601566
Websitehttps://www.clearmindmedicine.com/
BörsenkürzelCMND
IPO-datumAug 10, 2021
CEOZuloff-Shani (Adi)
Führungskräfte von Clearmind Medicine Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Clearmind Medicine Inc?
Die fünf größten Anteilseigner von Clearmind Medicine Inc sind: Mr. Amitay Weiss
Wie viele Institutionen halten Anteile an Clearmind Medicine Inc (CMND)?
Mit Stand vom 2026Q1 halten 18 Institutionen Anteile an Clearmind Medicine Inc, mit einem Gesamtmarktwert von etwa 7.38K, was 0.49% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -15258.00 gestiegen.